SEC Form D · filed February 7, 2023
Inhibikase Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Dennis Berman · Atlanta, GADirectorGisele Dion · Atlanta, GADirectorJoseph Frattaroli, C.P.A · Atlanta, GAExecPaul Grint, M.D · Atlanta, GADirectorMilton H. Werner Ph.D · Atlanta, GAExec · DirectorRoy Freeman M.D · Atlanta, GADirectorJoseph Frattaroli, C.P.A · Atlanta, GAExecPaul Grint, M.D · Atlanta, GADirectorMilton H. Werner Ph.D · Atlanta, GAExec · DirectorDennis Berman · Atlanta, GADirectorGisele Dion · Atlanta, GADirectorRoy Freeman M.D · Atlanta, GADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗